JPRN-UMIN000013439招募中2 期
The efficacy and safety of concurrent chemoradiotherapy for squamous cell carcinoma of the vulva. Phase II Study - ESCCSV TRIA
TGCU(Tohoku Gynecological Cancer Unit)0 个研究点目标入组 40 人开始时间: 2014年3月18日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 80years-old（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1. History of chemotherapy or radiotherapy 2. Active double cancer 3. Active infection 4. Severe complicating illness ( bronchial asthma, pneumonia, ischemic heart disease, diabetes mellitus, arrhythmia) 5. Massive ascites or pleural fluid 6. History of severe allergic reaction 7. pregnant, lactating women and women who expects pregnant 8. Difficult case to keep the regulations and observations 9. Other reason that primary doctor think ineligible
研究者
相似试验
已完成
不适用
Efficacy and toxicity of concomitant chemoradiation with weekly gemcitabine/cisplatin in comparison with weekly cisplatin in cervical cancer: a phase II, randomised trialCervical cancer (FIGO stage IB, II , III, IVA)Cervical cancerCancerISRCTN29976507Shaheed Beheshti University of Medical Science (SBMU) (Iran)80
已完成
2 期
Comparison of 3-weekly administration of continuous dose cisplatin with divided dose in head and neck carcinomaIRCT20201220049776N1Tehran University of Medical Sciences60
尚未招募
2 期
Prospective Study of Concurrent Chemoradiotherapy with S-1 and hypofractionated radiotherapy for outpatients with early glottic squamous cell carcinomasJPRN-UMIN000023416agoya University Graduate School of Medicine, Department of Radiology40
Unknown
3 期
A comparison of concurrent chemo-radiotherapy plus hyperthermia versus concurrent chemo-radiotherapy in locally advanced cervical cancer patients: A randomized controlled trial-This study aim to compare concurrent chemoradiotherapy and concurrent chemoradiotherapy plus hyperthermia in locally advanced cervical cancer in term of treatment response rate.Deep regional hyperthermiaThermotron-RF8radiation therapychemotherapyTCTR20180711002Chulabhorn Hospital, HRH Princess Chulabhorn College of Medical Science, Chulabhorn Royal Academy90
招募中
不适用
Clinical trial of concurrent chemoradiotherapy (CCRT) with S-1 in patients with advanced head and neck squamous cell carcinoma, who is not eligible for CCRT with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) regimeadvanced head and neck squamous cell carcinomaJPRN-UMIN000021870Yokohama City University hospital40